| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.11B | 26.50B | 22.02B | 21.40B | 21.25B | 20.53B |
| Gross Profit | 22.11B | 23.22B | 21.28B | 21.20B | 21.01B | 20.30B |
| EBITDA | 1.15B | 2.20B | 2.12B | 2.72B | 3.33B | 3.21B |
| Net Income | 404.00M | 596.00M | 860.00M | 1.25B | 1.60B | 1.61B |
Balance Sheet | ||||||
| Total Assets | 1.18T | 1.16T | 1.15T | 1.14T | 1.19T | 1.21T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 99.66B | 95.76B | 64.52B | 108.97B | 128.42B |
| Total Debt | 54.07B | 75.40B | 54.46B | 43.34B | 66.05B | 102.52B |
| Total Liabilities | 1.13T | 1.11T | 1.10T | 1.08T | 1.11T | 1.14T |
| Stockholders Equity | 52.30B | 45.90B | 50.70B | 58.65B | 73.77B | 71.32B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.69B | 0.00 | 0.00 | -32.97B | -35.05B |
| Operating Cash Flow | 0.00 | 9.56B | 0.00 | 0.00 | -31.98B | -34.28B |
| Investing Cash Flow | 0.00 | -5.61B | 6.28B | -5.94B | 6.11B | 2.49B |
| Financing Cash Flow | 0.00 | -314.00M | 2.90B | -17.96B | 6.35B | -462.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥77.52B | 8.35 | ― | 2.34% | 3.68% | 26.06% | |
71 Outperform | ¥116.16B | 5.37 | ― | 3.05% | 49.84% | 156.03% | |
71 Outperform | ¥266.40B | 14.34 | ― | 2.53% | 16.63% | 19.98% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥943.92B | 20.92 | ― | 2.10% | 8.96% | 42.70% | |
64 Neutral | ¥110.42B | 23.87 | ― | 2.46% | 16.88% | 59.34% | |
60 Neutral | ¥13.07B | 17.45 | ― | 2.74% | 17.43% | -35.15% |